rs10499194 — TNFAIP3
Intergenic regulatory variant at 6q23 near TNFAIP3 whose T allele is protective against rheumatoid arthritis in Europeans, representing the second independent RA signal at this locus alongside risk variant rs6920220
Details
- Gene
- TNFAIP3
- Chromosome
- 6
- Risk allele
- C
- Consequence
- Regulatory
- Inheritance
- Additive
- Clinical
- Protective
- Evidence
- Strong
- Chip coverage
- v3 v4 v5
Population Frequency
Ancestry Frequencies
Related SNPs
Category
Immune & GutSee your personal result for TNFAIP3
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
TNFAIP3 6q23 — The Protective Signal Next to the Brake
Six hundred kilobases along chromosome 6, near the TNFAIP3 gene that encodes the
A20 protein11 A20 protein
A20 is a ubiquitin-editing enzyme and the primary negative regulator of NF-κB inflammatory
signaling; TNFAIP3 stands for TNF Alpha Induced Protein 3,
lies a cluster of variants with independent and sometimes opposing effects on autoimmune disease risk.
rs10499194 is one of two independently associated signals at this 6q23 locus — but unlike its
risk-conferring neighbor rs6920220, this variant's minor (T) allele is protective against rheumatoid
arthritis and juvenile idiopathic arthritis in European populations. The T allele marks haplotypes
that appear to support more effective TNFAIP3 regulatory function, while the common CC genotype
represents the absence of this protection.
The Mechanism
rs10499194 sits in the intergenic region between OLIG3 and TNFAIP3, approximately 150 kb from the TNFAIP3
transcription start site and within the same ~60 kb linkage disequilibrium block as rs6920220. Both SNPs
lie within a region with no known protein-coding genes — they likely act through distal regulatory
elements22 distal regulatory
elements
Non-coding regulatory variants in this region have been shown to influence TNFAIP3 transcription
in reporter assays, consistent with enhancer or silencer activity.
The rs13207033 variant (a perfect genetic proxy for rs10499194 — the two are in complete linkage disequilibrium) was identified through conditional logistic regression as independently associated with RA after accounting for rs6920220. This means the protective signal at rs10499194 is not a statistical artifact of the nearby risk signal — it reflects a distinct, independent regulatory effect at the same locus. The two signals operate in opposite directions: rs6920220 A allele reduces TNFAIP3 expression (impaired A20 production, weakened NF-κB brake), while the rs10499194 T allele appears to tag a haplotype supporting adequate or enhanced TNFAIP3 regulatory activity.
The precise functional mechanism of rs10499194 itself has not been resolved as of publication of key studies — the variant may be a tag SNP for a causal regulatory element nearby rather than directly functional. This is typical for non-coding GWAS signals.
The Evidence
rs10499194 was first reported as an independent RA susceptibility locus33 first reported as an independent RA susceptibility locus
Plenge RM et al. Two
independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nature Genetics
2007 through genome-wide association in North American
and European cohorts (P=3×10⁻⁷), with replication in 5,541 additional case-control samples. Two
protective haplotypes are tagged by rs10499194, making it the anchor marker for the protective signal
at this locus. Association studies confirmed the two 6q23 signals (rs10499194 and rs6920220) are
statistically independent.
The combined model at 6q23 is quantified in a conditional analysis of three independent signals44 conditional analysis of three independent signals
Combined effects of three independent SNPs greatly increase the risk estimate for RA at
6q23. Individuals carrying both risk alleles at rs6920220
and rs5029937 while lacking the protective allele at rs10499194/rs13207033 have a combined OR of 1.86
(95% CI 1.51–2.29) for RA. The individual OR for the protective allele at rs10499194 (rs13207033
proxy) is 0.86 (95% CI 0.80–0.93). This means each copy of the T allele reduces RA odds by approximately
14% in European populations.
Protection extends to juvenile idiopathic arthritis55 juvenile idiopathic arthritis
Variants in TNFAIP3, STAT4, and C12orf30 loci
associated with multiple autoimmune diseases are also associated with JIA,
where the T allele conferred significant protection (OR 0.74, 95% CI 0.61–0.91, P<0.004) across a
multi-cohort European JIA study. The effect size is stronger for JIA than for adult RA, possibly
reflecting earlier-onset disease having a higher genetic loading.
A meta-analysis of 13 case-control studies66 meta-analysis of 13 case-control studies
15,341 RA cases and 24,535 controls across multiple
populations confirmed the protective effect of the TT
genotype in Caucasians (OR 0.79, 95% CI 0.72–0.86) but found no protective effect in East Asian or
African-American populations. Strikingly, East Asian cohort data77 East Asian cohort data
Single nucleotide polymorphisms
in TNFAIP3 were associated with RA risk in northern Chinese Han
population shows the T allele is actually a risk allele
in Chinese Han populations (CT OR 2.00), where the T allele occurs at low frequency (~5%) and likely
tags a different haplotype with distinct functional consequences. This is a classic example of
population-specific linkage disequilibrium patterns reversing apparent effect directions.
Unlike rs6920220, rs10499194 shows no significant association with systemic lupus erythematosus — the protective effect is more specific to RA and JIA within the autoimmune disease spectrum.
Two well-powered interventions target the NF-κB pathway that TNFAIP3 controls. The VITAL randomized
trial88 VITAL randomized
trial
25,871 participants randomized to vitamin D3 2000 IU/day or omega-3 1g/day vs
placebo found vitamin D supplementation reduced incident
autoimmune disease by 22% and omega-3 reduced by 15%, with benefits persisting two years after
supplementation ended. For CC carriers who lack the T-allele protection, these NF-κB-modulating
interventions represent the most evidence-backed compensatory strategy.
Interactions
rs10499194 is one of three independent association signals at the 6q23 locus. The complete risk model integrates this protective signal with the risk signal rs6920220 and a third signal rs5029937 (intronic in TNFAIP3). CC homozygotes at rs10499194 who also carry risk alleles at rs6920220 and rs5029937 face a combined OR of 1.86 — the highest-risk combination at this locus. The protective T allele at rs10499194 partially offsets rs6920220 risk when both are present.
The TNFAIP3 missense variant rs2230926 (F127C) impairs A20 enzymatic activity through a completely independent mechanism. CC carriers at rs10499194 combined with the G allele at rs2230926 could have compounded NF-κB dysregulation — reduced regulatory support from the locus combined with impaired A20 catalytic function. This combination warrants compound action assessment.
PTPN22 R620W (rs2476601) and the broader TNFAIP3 locus (rs6920220) define the main European RA genetic risk context. Each SNP operates through distinct mechanisms converging on T-cell activation thresholds and NF-κB regulation.
Genotype Interpretations
What each possible genotype means for this variant:
Two T alleles — strongest 6q23 protective genotype for RA
You carry two copies of the protective T allele, conferring the strongest protection available at this 6q23 locus. Meta-analysis of Caucasian populations found the TT genotype is associated with OR 0.79–0.80 for RA — a ~20% reduction in RA odds compared to CC carriers. This genotype also protected against juvenile idiopathic arthritis (OR 0.74 per T allele) in European cohorts. About 9% of people of European descent share this genotype. This protection operates independently of the rs6920220 signal and partially offsets any risk from carrying A alleles at that companion locus.
One T allele — partial protection against RA at the 6q23 locus
You carry one copy of the protective T allele, giving you partial protection against rheumatoid arthritis from this 6q23 signal. Heterozygotes benefit from the protective haplotype tagged by the T allele but with approximately half the benefit of TT homozygotes. The individual protective effect of the T allele at this locus is OR 0.86 per allele in Europeans — modest protection that becomes clinically meaningful in the context of your overall 6q23 genetic profile. About 39% of people of European descent share this genotype.
Common genotype — no T-allele protection against NF-κB dysregulation at 6q23
The CC genotype lacks both copies of the rs10499194 T allele, which tags protective haplotypes at the 6q23 locus. In the three-signal model at this locus, CC homozygotes contribute the absence of the protective allele at rs13207033 (perfect proxy for rs10499194) — one of three components that, when combined with rs6920220 A allele and rs5029937 T allele, yields a combined OR of 1.86 for RA.
The East Asian data is important context: in Chinese Han populations, the C allele is the major allele (~95%) and the T allele occurs at very low frequency (~5%). The T allele in that population appears to tag a different haplotype and is associated with increased RA risk (OR 2.00) rather than protection. This population-specific effect is due to differences in linkage disequilibrium — the same letter allele can tag functionally opposite haplotypes in different populations. European CC genotype interpretation does not apply to East Asian individuals.
Key References
Original discovery — rs10499194 independently associated with RA at 6q23 (P=3×10⁻⁷) in genome-wide scan and 5,541 replication samples; two haplotypes tagged by rs10499194 are protective; independent of rs6920220 risk signal (Nature Genetics 2007)
Combined effects of three independent 6q23 SNPs: rs10499194 protective allele absence + rs6920220 risk + rs5029937 risk yields combined OR 1.86 (95% CI 1.51–2.29); rs13207033 is a perfect proxy for rs10499194
T allele at rs10499194 protects against juvenile idiopathic arthritis (OR 0.74, 95% CI 0.61–0.91, P<0.004) in multi-cohort European JIA study
Meta-analysis of 13 case-control studies (15,341 cases/24,535 controls): TT vs CT+CC OR 0.80 (95% CI 0.74–0.88); Caucasian-specific OR 0.79; no protective effect in East Asians or African-Americans
Chinese Han RA cohort: rs10499194 T allele is a RISK allele in East Asians (CT OR 2.00, 95% CI 1.46–2.74); opposite direction to European protective effect, illustrating population-specific LD reversal
VITAL RCT (25,871 participants): vitamin D 2000 IU/day reduced incident autoimmune disease by 22% (HR 0.78, P=0.05); omega-3 1g/day reduced by 15%, with sustained effects post-trial
Meta-analysis of TNFAIP3 polymorphisms in RA: rs10499194 significant in Asians (OR 1.254, 95% CI 1.101–1.429); Europeans showed no association in this analysis (underpowered), highlighting population heterogeneity